Articles

FROM DR. FEIN'S DRUG CHANNELS BLOG

Diplomat Sees Declining DIR Fee Impact—and Perhaps Readies...

Last week, Diplomat Pharmacy released its quarterly earnings, which included new details about the financial impact of Direct and Indirect Remuneration (DIR) fees. I provide some background on DIR fees...

read more

Electronic Benefit Verification & Prior Authorization Summit

Electronic Benefit Verification & Prior Authorization Summit October 24-25, 2017 | San Francisco, CA www.cbinet.com/eBenefit CBI’s Electronic Benefit Verification & Prior Authorization Summit provides attendees with an understanding of key...

read more

Generic Deflation Roils the Channel—And Will Get Worse

Deflation in generic drug prices dragged down second quarter earnings for drug wholesalers and generic manufacturers. Here’s a useful summary from The Wall Street Journal, which captures the grim marketplace...

read more

industry reports